No Data
No Data
Earnings Week Ahead: Nike, Carnival, Constellation Brands, and More
Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events
Barrington Maintains Lifecore Biomedical(LFCR.US) With Hold Rating
Barrington analyst Michael Petusky maintains $Lifecore Biomedical(LFCR.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 50.4% and a total average return of 5.8%
Lifecore Biomedical (LFCR) Gets a Hold From Barrington
Craig-Hallum Maintains Lifecore Biomedical(LFCR.US) With Buy Rating
Craig-Hallum analyst Matt Hewitt maintains $Lifecore Biomedical(LFCR.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 42.4% and a total average return of -4.2%
Craig-Hallum Sticks to Their Buy Rating for Lifecore Biomedical (LFCR)